King Pharms announces FDA approves EMBEDA for management of moderate to severe chronic pain.
Thursday, August 13, 2009
Subscribe to:
Post Comments (Atom)
Blog Archive
-
▼
2009
(252)
-
▼
August
(58)
- Consumer-less recovery
- SPY -- Rally -- Volume ??
- Short accumulation
- AIG momentum impacts low-quality financial stocks...
- Select shippers moving higher
- DBLE
- ADLR
- Consumer is not participating in jobless recovery
- Perspective
- Great action today, market allowed me to build a d...
- SPX
- FAZ
- Encima Global is predicting that unemployment in t...
- RTK
- Overseas
- Commentary
- Selling 50% position RTK (taking profits), continu...
- RTK
- No title
- Adding to my swing short position on financials. FAZ
- The EconomyHousing starts fell in July, according ...
- SP 500 - McClaren Target
- FAZ
- QQQQ
- Overseas Selling
- RTK - continue long
- KG
- 30 Yr Bond Auction
- Market disconnect
- FAZ - exit $28.20
- FAZ
- RTK - Exit $1.34
- FAZ - Exit $27.50
- FAZ
- FNM
- HGSI
- Commentary
- No title
- MPG
- The stock market keeps momentum, frustrating the s...
- RTK - continue long
- Week's winners
- FAZ
- Here comes the squeeze, out for now and on the sid...
- Strong financials make it difficult to have a real...
- Good economic news presents a classic profit-takin...
- SDS continue to short the market, long RTK
- Trading Radar
- RTK
- CIT Picture Perfect
- Financials XLF continue to outperform broader-mar...
- SDS
- SDS
- XLF
- 91% of the S&P 500 stocks, or 455 of them, are cur...
- STEC beats by $0.08, beats on revs and guides high...
- S&P 500 trading above 1,000 for the first time sin...
- Broad-based buying continues to lift stocks despit...
-
▼
August
(58)
No comments:
Post a Comment